Decontamination of the digestive tract and oropharynx: hospital acquired infections after discharge from the intensive care unit by de Smet, Anne Marie G. A. et al.
Anne Marie G. A. de Smet
Titia E. M. Hopmans
Albertus L. C. Minderhoud
Hetty E. M. Blok
Annelies Gossink-Franssen
Alexandra T. Bernards
Marc J. M. Bonten
Decontamination of the digestive tract and
oropharynx: hospital acquired infections
after discharge from the intensive care unit
Received: 6 January 2009
Accepted: 1 June 2009
Published online: 24 June 2009
 The Author(s) 2009. This article is
published with open access at
Springerlink.com
A. M. G. A. de Smet ())
Division of Perioperative and Emergency
Care, University Medical Center Utrecht,
Heidelberglaan 100, 3584 CX Utrecht,
The Netherlands
e-mail: a.desmet@umcutrecht.nl
Tel.: ?31-88-7555555
Fax: ?31-30-2541828
T. E. M. Hopmans  A. L. C. Minderhoud 
H. E. M. Blok  M. J. M. Bonten
Department of Medical Microbiology,
University Medical Center Utrecht,
Heidelberglaan 100, 3584 CX Utrecht,
The Netherlands
A. Gossink-Franssen
Department of Infectious Diseases, Leiden
University Medical Center, Albinusdreef 2,
2333 ZA Leiden, The Netherlands
A. T. Bernards
Department of Medical Microbiology,
Leiden University Medical Center,
Albinusdreef 2, 2333 ZA Leiden,
The Netherlands
Abstract Objective: To determine
the incidence rates of hospital
acquired infections (HAI) during the
ﬁrst 14 days after ICU discharge after
treatment during ICU-stay with
Selective Decontamination of the
Digestive tract (SDD), Selective
Oropharyngeal Decontamination
(SOD) or Standard Care (SC).
Design: Prospective observational
study. Setting: ICUs in two tertiary
care hospitals. Patients: Patients
discharged from the ICU to the ward.
Interventions: None. Measurements
and results: Post-ICU incidences of
HAI per 1,000 days at risk were 11.2,
12.9 and 8.3 for patients that had
received SDD (n = 296), SOD
(n = 286) or SC (n = 289)
respectively in ICU, yielding relative
risks, as compared to SC, of 1.49
(CI95 0.9–2.47) for SOD and 1.44
(CI95 0.87–2.39) for SDD. Incidences
of surgical site infections (per 100
surgical procedures) were 4 after SC
and 11.8 and 8 after SOD and SDD
(p = 0.04). Among patients that suc-
cumbed in the hospital after ICU-stay
(n = 58) eight (14%) had developed
HAI after ICU discharge; 3 of 21 after
SDD, 3 of 15 after SOD and 2 of 22
after SC. Conclusions: Incidences
of HAI in general wards tended to be
higher in patients that had received
either SDD or SOD during ICU-stay,
but it seems unlikely that these
infections have an effect on hospital
mortality rates.
Keywords SDD  SOD 
Critically ill patients  Intensive care 
Hospital acquired infections
Introduction
Prophylactic antibiotic regimens, such as Selective
Decontamination of the Digestive tract (SDD) and
Selective Oropharyngeal Decontamination (SOD), reduce
the incidence of respiratory tract infections (RTI) in
Intensive Care Unit (ICU) patients and improve survival
[1–6]. The concept of SDD, developed in the 1980s [7, 8]
consists of prevention of secondary colonization with
Gram negative bacteria, S. aureus, and yeasts through
application of non-absorbable antimicrobial agents in the
oropharynx and gastrointestinal tract. Further it consists
of pre-emptive treatment of possible infections due to
commensal respiratory tract bacteria through systemic
administration of cephalosporins during the ﬁrst four days
in ICU and maintaining the anaerobic intestinal ﬂora
through the use of antibiotics (both topically and sys-
temically) not active against anaerobic bacteria [8]. In
meta-analyses, three single center randomized studies and
a recent multi-center trial, SDD was associated with
improved patient survival [1, 4, 6, 9–11]. SOD (applica-
tion of topical antibiotics in the oropharynx only) might
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reducing day 28 mortality in a recent multi-center study
[6].
SDD (and to lesser extent SOD) aim to extensively
modulate the microbial ecology of patients. It is
unknown how discontinuation of these interventions at
ICU discharge changes the patients’ microbial ecology
and whether this inﬂuences their immediate risk of
infections. The current study was motivated by the
ﬁndings from de Jonge et al. [4]. In their SDD study the
observed relative risk reduction (RRR) in ICU mortality
of 35% reduced to 22% at hospital discharge. This
reduction in survival beneﬁt after ICU discharge might
have been related to an increased incidence of hospital
acquired infection (HAI) in those patients that had
received SDD in ICU. Nested within a multi-center
SDD–SOD trial we prospectively monitored the occur-
rence of HAI during the ﬁrst 14 days after ICU
discharge in all patients trans f e r r e dt or e g u l a rw a r d si n
two university hospitals.
Patients and methods
Setting
The study was conducted in two tertiary care hospitals:
the University Medical Center Utrecht and the Leiden
University Medical Center. Nested within a multi-center
SDD–SOD trial [6], the occurrence of HAI during the ﬁrst
14 days after ICU discharge was prospectively monitored
in all patients transferred to regular wards.
Study design, data collection and deﬁnitions
In ICU, patients with an expected stay C72 h, or with an
expected duration of mechanical ventilation C48 h, had
received either SDD, SOD or standard care (SC), which
rotated in 6-month periods, as described previously [6].
Data were collected from patient records for a maxi-
mum of 14 days post-ICU. The following data were
recorded for each patient: gender, age, length of stay at
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Fig. 1 Flowchart
1610the ICU, mechanical ventilation and APACHE II score at
the ICU. At the wards, medical records were prospec-
tively reviewed twice weekly by an Infection Control
Professional for HAI according to the Centers for Disease
Control and Prevention (CDC) deﬁnitions [12, 13].
In the surveillance period the following HAIs (and
day of diagnosis) were registered in both hospitals: sur-
gical site infections (SSI), bloodstream infections (BSI),
and RTI. In one of the hospitals, oropharyngeal infections
were also registered. Infection control policies (other
than the subject of the study) did not change during the
period of the study in either hospital.
Data analysis
The incidence of HAI was expressed per 1,000 days at
risk, i.e. days until ﬁrst HAI, day of discharge or end of
observation period. The proportion of patients with HAI
was expressed as the total number of patients with HAI
per 100 patients surveyed post-ICU, with 95%-conﬁ-
dence interval (CI95). The total number of SSIs was
expressed per 100 patients with surgical procedures.
Statistical analysis was performed with SPSS for Win-
dows 12.0.1 (SPSS, Inc., Chicago, IL, USA). Differences
in continuous variables between groups were determined
by Student’s t test. Differences in proportions of HAI
(with CI95) in the successive study periods were deter-
mined. Statistical signiﬁcance was deﬁned as a p value of
less than 0.05.
Results
Patients
Between May 2004 and July 2006, 871 patients were
included; 289 after SC, 286 after SOD and 296 SDD
(Fig. 1). Reasons for patients being lost to follow-up
(n = 122) mainly included their transfer to other hospitals
after ICU discharge. Although fewer patients in the SC
group had received mechanical ventilation in ICU (84%
vs. 96% and 94% in SOD and SDD, respectively), other
characteristics (such as age, sex, Apache II-score on
ICU admission and surgical or non-surgical reasons
for admission) were comparable for all three groups
(Table 1).
End points
The numbers of patients with HAI were 23, 34 and 34
from the SC, SOD and SDD groups, respectively, yielding
incidences per 1,000 days at risk of 8.3, 12.9 and 11.2 for
SC, SOD and SDD, respectively (Table 2). As compared
to SC, the relative risks for developing HAI in the ﬁrst
14 days after ICU discharge were 1.49 (CI95 0.9–2.47)
after SOD and 1.44 (CI95 0.87–2.39) after SDD. Oro-
pharyngeal infections, only registered in one hospital,
occurred in one patient after SC and in four patients after
SOD.
Most infections were RTI, with similar incidences and
similar time until diagnosis in all three study groups
(Table 2). Adjustment for the difference in number of
mechanically ventilated patients in ICU did not change
these observations. Incidences of BSI were also similar
between the three groups, but the duration until infection
tended to be longer in the post-intervention groups (means
of 4.8 for SC and 7.7 days for SOD and SDD combined,
p = 0.17 when comparing SC to SDD and SOD com-
bined). Incidences of SSI, expressed per 100 surgical
procedures were 4 after SC, as compared to 11.8 after
SOD and 8 after SDD (p = 0.04 when comparing SC to
SDD and SOD combined). Among the 26 patients with
SSI in both post-intervention groups, 18 were diagnosed
with superﬁcial infections (15 patients not cultured or
with a negative culture) and in 7 patients Staphylococcus
aureus was documented as the cause of SSI.
Hospital mortality was 7.6% (22 patients) in the SC
group, 5.2% (15 patients) in the SOD group and 7.1% (21
patients) in the SDD group. Hospital mortality among
Table 1 Patients’ characteristics
Standard care SOD SDD
No. of patients 289 286 296
Sex (male/female) 187/102 181/105 180/116
Age
Mean (median) 56.7 (59) 57.9 (61) 57.0 (60)
SD 18 17.1 17.5
Range 16–93 12–87 16–87
APACHE II at ICU admission
Mean (median) 18.9 (18) 19.8 (19) 20.1 (19)
SD 7.85 7.86 7.98
Range 4–48 4–45 0–45
LOS in ICU
Mean (median) 13.6 (8) 12.6 (8) 14.2 (9)
SD 15 11.8 15.1
Range 1–141 1–93 1–121
Mechanical ventilation in ICU
Yes (%) 243 (84)* 274 (96)* 279 (94)*
No 46 12 17
Specialty
Cardiology 9 15 10
Cardiothoracic surgery 13 27 16
Surgery 109 94 117
Medical 61 54 61
Pulmonology 8 8 7
Neurosurgery 38 49 43
Neurology 28 26 23
Other 23 13 19
No. of surgical patients 126 127 137
LOS Length of stay
* Standard care versus SOD and SDD signiﬁcantly different
(p = 0.000), no difference between SOD and SDD
1611patients that developed HAI was 8.7% (n = 2), 8.8%
(n = 3) and 8.8% (n = 3).
Discussion
Incidences of HAI in general wards tended to be higher in
patients that had received either SDD or SOD during
ICU-stay, but it seems unlikely that these infections have
an important effect on hospital mortality rates. Of note,
the observed differences in relative risks only approached
statistical signiﬁcance.
To the best of our knowledge this is the ﬁrst study that
has quantiﬁed timing and incidences of infections in
general wards after ICU discharge related to antimicrobial
infection prevention measures in the ICU. Strengths
include the prospective monitoring of infections per-
formed by a limited number (n = 3) of trained and
experienced infection control professionals. The open
study design in the ICU was an unavoidable limitation of
thepresentanalysis.Byusingobjective,andinternationally
accepted, criteria we aimed to minimize information bias.
The fact that the study was performed in only two ter-
tiary care centers may reduce the generalizability of our
ﬁndings.
The observed tendency towards a higher infection rate
after an antibiotic intervention in ICU might be related to
differences in patient risk factors or to changes in the
colonization status between the intervention groups and
the patients that received standard care. Indeed, at the
time of ICU admission, a higher proportion of patients in
the standard group did not receive mechanical ventilation.
Yet, there were no signiﬁcant differences in age,
APACHE II score at the time of ICU admission or the
lengths of stay in ICU or on mechanical ventilation, or in
distribution of medial specialties. We therefore assume
that the risk proﬁle at the time of ICU discharge was
similar for the three patient populations.
Both SDD and SOD aim to modulate the colonization
status of patients, which resulted in lower colonization
rates with Gram negative bacteria in the respiratory and
intestinal tract [6]. After discontinuation of the prophy-
lactic regimens, though, patients may acquire colonization
with typical hospital pathogens or suppressed coloniza-
tion with such bacteria may reemerge. If these phenomena
Table 2 Infections, time until
diagnosis and mortality Standard care
(N = 289)
SOD
(N = 286)
SDD
(N = 296)
Number of patients with HAI 23 34 34
Number of HAI 26 39 37
Incidence of HAI/1,000 days at risk 8.3 12.9 11.2
RR standard care versus intervention – 1.49 1.44
CI95 0.9–2.47 0.87–2.39
Proportion of patients (%)with HAI 8 12 11
CI95 5–12 8–16 8–16
Specialty of patients with HAI
Cardiology 1 2 –
Cardiothoracic surgery – 2 –
Surgery 12 14 19
Medical 2 7 4
Pulmonology – – –
Neurosurgery 3 3 6
Neurology 2 4 3
Other 3 2 2
Mortality: no. of patients (%) 22 (7.6) 15 (5.2) 21 (7.1)
Mortality of patients with HAI: no. of patients (%) 2 (8.7) 3 (8.8) 3 (8.8)
Mean LOS in surveillance on ward (days) 10.1 10.0 11.0
Median; range 13; 1–14 14; 1–14 14; 1–14
No. of RTI 16 18 18
Mean time until diagnosis (days) 4.6 5.0 4.7
Median; range 4.5; 1–9 4.5; 1–13 3.5; 1–12
No. of BSI 5 5 8
Mean time until diagnosis (days) 4.8 5.6 9.0
Median; range 4.0; 1–8 5; 2–12 10; 1–12
No. of SSI 5 15 11
Incidence/100 surgical procedures 4.0 11.8 8.0
Differences in times until diagnosis are not signiﬁcant between the three groups or between the
standard care group versus SOD and SDD combined
HAI Hospital acquired infections, RR relative risk, LOS length of stay, RTI respiratory tract infection,
BSI blood stream infection, SSI surgical site infection
The proportion of patients with HAI in the standard care period versus SOD and SDD combined (RR
1.47, CI95 0.935–2.305) is not signiﬁcantly different
1612are relevant, and whether they are responsible for our
observations, remains to be determined.
Our study was motivated by the observation of a
tendency towards higher mortality rates after ICU dis-
charge among patients that had received SDD in a
previous study [4]. In the current study, 58 patients (7%)
succumbed in the hospital after ICU discharge, and eight
(14%) of these patients had been diagnosed with a HAI in
the ﬁrst 14 days after ICU discharge. Overall mortality
rates were comparable between the three study groups and
the numbers of patients that died after developing a HAI
was two in the standard care period and three in both the
SDD and SOD period. Considering the low rates of
infection, the overall low mortality rates after ICU
discharge and the low prevalence of infections among
those that succumbed after ICU discharge, we reject the
hypothesis that an increased infection rate after ICU
discharge affects the clinical outcome of patients that
have received SDD or SOD in ICU, in spite of a tendency
of more infections, especially superﬁcial SSIs, in these
patients after ICU discharge.
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